Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Multi-Drug-Resistant Tuberculosis: A Global Health Crisis in the Making

Author(s): Rosapaulina Huerta, Valeria Garcia-Gaytan and Joseph Varon

Volume 21, Issue 1, 2025

Published on: 28 August, 2024

Page: [3 - 5] Pages: 3

DOI: 10.2174/1573398X2101240828103759

Open Access Journals Promotions 2
« Previous Next »
[1]
Tiberi S, Utjesanovic N, Galvin J, et al. Drug-resistant TB - latest developments in epidemiology, diagnostics, and management. Int J Infect Dis 2022; 124(1): 24-5.
[http://dx.doi.org/10.1016/j.ijid.2022.03.026]
[2]
World Health Organization. Tuberculosis deaths and disease increase during the COVID-19 pandemic. 2022. Available from: https://www.who.int/news/item/27-10-2022-tuberculosis-deaths-and-disease-increase-during-the-covid-19-pandemic
[3]
Ichsan I, Redwood-Campbell L, Mahmud NN, et al. Risk factors of MDR-TB and impacts of the COVID-19 pandemic on the escalating incidence of MDR-TB in lower-middle-income countries: A scoping review. Narra J 2023; 3(2): 1-13.
[4]
Schami A, Islam MN, Belisle JT, et al. Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host. Front Cell Infect Microbiol 2023; 13: 1-14.
[http://dx.doi.org/10.3389/fcimb.2023.1274175]
[5]
Khawbung JL, Nath D, Chakraborty S. Drug-resistant tuberculosis: a review. Comp Immunol Microbiol Infect Dis 2021; 74: 101574.
[http://dx.doi.org/10.1016/j.cimid.2020.101574]
[6]
Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, et al. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis 2020; 92: S15-25.
[http://dx.doi.org/10.1016/j.ijid.2020.01.042]
[7]
Wells C, Severn M. Incentives and support programs to improve adherence to tuberculosis treatment. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health 2021.
[8]
Tu H-A, Vu HD, Rozenbaum MH, et al. A literature review on the economics of vaccination against TB. Expert Rev Vaccines 2012; 11(3): 303-17.
[http://dx.doi.org/ 10.1586/erv.11.197]
[9]
Harries AD, Kumar AMV, Satyanarayana S, et al. The growing importance of tuberculosis preventive therapy and how research and innovation can enhance its implementation. Trop Med Infect Dis 2020; 5(2): 61-2.
[http://dx.doi.org/ 10.3390/tropicalmed5020061]
[10]
Yusoof KA, García JI, Schami A, et al. Tuberculosis phenotypic and genotypic drug susceptibility testing and immunodiagnostics: a review. Front Immunol 2022; 13: 870768.
[http://dx.doi.org/10.3389/fimmu.2022.870768]
[11]
Allué-Guardia A, Saranathan R, Chan J, et al. Mycobacteriophages as potential therapeutic agents against drug-resistant tuberculosis. Int J Mol Sci 2021; 22(2): 735.
[http://dx.doi.org/10.3390/ijms22020735]
[12]
Huerga H, Khan U, Bastard M, et al. Safety and effectiveness outcomes from a 14-country cohort of patients with multi-drug resistant tuberculosis treated concomitantly with bedaquiline, delamanid, and other second-line drugs. Clin Infect Dis 2022; 75(8): 1307-14.
[http://dx.doi.org/10.1093/cid/ciac176]
[13]
Akalu TY, Clements ACA, Wolde HF, et al. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis. Sci Rep 2023; 13(1): 22361.
[14]
Akalu TY, Clements ACA, Wolde HF, et al. Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis. EClinicalMedicine 2023; 57: 101900.
[15]
Singla R, Mallick M, Mrigpuri P, et al. Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment. Lung India 2018; 35(1): 4-8.

Rights & Permissions Print Cite
Article Metrics
6
1
Wayfinder Image
Open Access Journals Promotions
World Pneumonia Day
© 2024 Bentham Science Publishers | Privacy Policy